Beta Bionics, Inc. Common Stock (BBNX) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $13.02
• Market Cap: $571.81M
• EPS: $-1.81
• 52-Week High: $32.71
• 52-Week Low: $8.89

Market Sentiment

Beta Bionics, Inc. Common Stock currently has a Bearish sentiment score of -0.32.

About Beta Bionics, Inc. Common Stock

Beta Bionics, Inc. (BBNX) is a pioneering medical device company headquartered in Irvine, California, dedicated to revolutionizing diabetes management through innovative insulin delivery systems. By leveraging advanced technology and a patient-centric approach, Beta Bionics strives to enhance the quality of life for individuals dependent on insulin, addressing critical needs within the diabetes community. With a robust focus on research and development, the company is well-positioned to lead ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Beta Bionics, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BBNX pay dividends?

Beta Bionics, Inc. Common Stock (BBNX) does not currently pay a regular dividend.

What is BBNX's market cap?

Beta Bionics, Inc. Common Stock (BBNX) has a market capitalization of $571.81M with a current stock price of $13.02.